Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Antibody-Drug Conjugates (ADCs): Precise and selective weapons against cancer

Share this TechNote

Never miss a new TechNote!

Receive our TechNotes as soon as they are published.


Follow Us!

Reference:
R.S. Zolot, et al. (2013) Nat. Rev. Drug Discov. 12, 259.

Application Note:
Working together, Enzo Life Sciences and Innate Pharma validated the use of the ProteoStat® Aggregation Assay and ProteoStat® Thermal Shift Assay for ADC discovery research. Please contact us to get a copy of our application note on ADC

Better Detection Upstream
Maximum Production Downstream

Innovative Tools for Biotherapeutics Development

Bioprocess

Latest Literature

Brochures
Bioprocess - Innovative tools for biotherapeutics development
 
comments powered by Disqus

Related Products

PROTEOSTAT® Protein aggregation assay 

Quantitative Detection of  Protein Aggregates from Visible to Subvisible Particles
Flow Cytometry, Fluorescence microscopy, Fluorescent detection, Microplate | Print as PDF
 
ENZ-51023-KP050 50 tests 201.00 USD
 
ENZ-51023-KP002 2x96 tests 542.00 USD
Do you need bulk/larger quantities?
 

PROTEOSTAT® Thermal shift stability assay kit 

Accelerated screening for protein stability as a function of pH,  ionic strength, and concentration.
Print as PDF
 
ENZ-51027-K100 100 tests 202.00 USD
 
ENZ-51027-K400 400 tests 543.00 USD
Do you need bulk/larger quantities?
 

PROTEOSTAT® Protein aggregation standards  

The only commercially available protein aggregation standards assay!
Fluorescent detection, Microplate | Print as PDF
 
ENZ-51039-KP002 2x96 wells 243.00 USD
Do you need bulk/larger quantities?
 

PROTEOSTAT® Protein refolding and aggregation sensing kit  

Identify Optimal Protein Refolding Conditions and Maximize Recovery of Functional Protein
Print as PDF
 
ENZ-51040-KP002 2x96 wells 417.00 USD
Do you need bulk/larger quantities?
 

Recommend this page

 
Keep in touch

©2022 Enzo Life Sciences, Inc.,